Endocytosis of insulin at the blood-brain barrier
Frontiers in Drug Delivery · 2022
DOI: 10.3389/fddev.2022.1062366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Drug Delivery, 2022. Verfasst von Sarah Pemberton und 4 weiteren Autor:innen. Beteiligte Einrichtung: Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIA NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
For insulin to act within the brain, it is primarily transported from the blood across the blood-brain barrier (BBB). However, the endocytic machinery necessary for delivering insulin to the brain remains unknown. Additionally, there are processes within the brain endothelial cell that are designed to respond to insulin binding and elicit intracellular signaling. Using pharmacological inhibitors of different types of endocytosis (clathrin-vs. caveolin-mediated), we investigated molecular mediators of both insulin BBB binding in isolated mouse brain microvessels and BBB insulin transport in mice studied by brain perfusion. We found clathrin-mediated mechanisms responsible for insulin surface binding in isolated brain microvessels while caveolin-mediated endocytosis may mediate BBB insulin transport specifically in the hypothalamus. These results further define the molecular machinery necessary for transporting insulin into the CNS and highlight the distinction between insulin internalization for transendothelial transport vs. intracellular signaling.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Geriatric Research Education and Clinical Center, VA Puget Sound Health Care System, Seattle, WA, United States.
- Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, United States.
- Division of Gerontology and Geriatric Medicine, Department of Medicine, School of Medicine, University of Washington, Seattle, WA, United States.
Förderung
- NIDDK NIH HHS
- NIA NIH HHS
- National Institutes of Health
Zitieren
APA
Pemberton, S., Galindo, D. C., Schwartz, M. W., Banks, W. A., & Rhea, E. M. (2022). Endocytosis of insulin at the blood-brain barrier. Frontiers in Drug Delivery. https://doi.org/10.3389/fddev.2022.1062366
Vancouver
Pemberton S, Galindo DC, Schwartz MW, Banks WA, Rhea EM. Endocytosis of insulin at the blood-brain barrier. Frontiers in Drug Delivery. 2022. doi:10.3389/fddev.2022.1062366
BibTeX
@article{Pemberton2022,
author = {Pemberton, Sarah and Galindo, Demi C and Schwartz, Michael W and Banks, William A and Rhea, Elizabeth M},
title = {Endocytosis of insulin at the blood-brain barrier},
journal = {Frontiers in Drug Delivery},
year = {2022},
doi = {10.3389/fddev.2022.1062366}
}
EUVIMED